Heart devices reduce hospitalization, study says
Wall Street Journal, September 1, 2009
Results from an industry-funded study of cardiac resynchronization therapy defibrillators, medical implants that slow heart deterioration, found benefits more pronounced than in a preliminary analysis in June. But some cardiologists remain skeptical that the findings justify broad use of the $30,000 devices for patients with mild heart failure.
- Why Is Healthcare Price Transparency So Hard?
- EHR Spending Continues, But Jury Still Out on ROI
- 5 Hot Healthcare Ideas from SXSW
- Adverse Events from Insulin Prescribing 'An Epidemic'
- Payers Detail Strategies That Drive Consumer Satisfaction
- Hospital Groups Strike Back at Hospital Rating Systems
- Care Coordination a Cost-Cutting Quality Driver
- Use of Locum Tenens Up 22% in One Year
- 4 Marketing Tactics for Hospitals on Instagram
- Hospital CEO Turnover Hits Record High